The global surgical navigation system market reached RMB 74.978 billion in 2022. The market is projected to reach RMB 163.622 billion by 2028, growing at a rate of 13.89%. Accurate positioning and visualization are key to successful surgical navigation. For example, spinal surgery navigation systems require preoperative planning to accurately locate anatomy and surgical sites, helping surgeons select the optimal surgical path and minimize surgical trauma, thereby improving surgical efficiency. Common positioning systems utilize technologies such as mechanical positioning, ultrasonic positioning, electromagnetic positioning, and optical positioning. Currently, the National Medical Products Administration has approved several imported and domestically produced surgical navigation systems for clinical use, including those from Medtronic, BrainLab AG, Beijing Tianzhihang, Huake Precision, and Beijing Baihui Weikang.
However, in surgical procedures, such as orthopedics, the spinal cord and nervous system adjacent to the spine are often not visible during surgery, making such procedures risky and challenging. During surgery, doctors primarily rely on CT scans or MRIs to obtain anatomical information about the affected area, typically displayed on a screen. While these methods can provide some assistance, they ultimately rely on the surgeon's extensive experience and skillful technique, making these procedures challenging and risky.
Augmented Reality (AR) surgical navigation technology was developed to address these issues. Based on medical imaging data, it creates a virtual reality space and combines it with 3D visualization technology to simulate key surgical steps. Using a spatial positioner, it tracks the position of surgical instruments relative to the lesion, projecting this information onto preoperative or intraoperative patient images in real time. This image is then presented to the surgeon using AR display technology, thereby guiding the procedure. AR technology can overlay a virtual scene containing 3D information with the real world, freeing it from the limitations of display screens and significantly improving the intuitiveness, precision, and real-time nature of surgical procedures.
Internationally, the U.S. Food and Drug Administration (FDA) has approved several AR-based medical devices for marketing, including Novarad Corporation's OpenSight system and VisAR system, and Augmedics Ltd.'s xvision Spine system (XVS). These devices have demonstrated promising results in spinal surgery and improved surgical quality. In recent years, my country has also conducted cutting-edge research in the medical field using AR technology, achieving significant progress. However, there are currently no mature systems in clinical use, nor are there any approved AR medical devices. While the clinical application of AR technology requires the development of products that better meet clinical needs, the evaluation system for AR-based visualization medical devices is still underdeveloped, significantly increasing the difficulty of market entry for these products.





